慢性阻塞性肺疾病合并肺栓塞临床诊疗的研究进展
Research progress on the clinical diagnosis and treatment of COPD with pulmonary embolism
王丽芳 1李琪 2周向东2
作者信息
- 1. 海南医学院第一附属医院呼吸内科,海南 海口 570102
- 2. 海南医学院第一附属医院呼吸内科,海南 海口 570102;海南省呼吸疾病临床医学中心,海南 海口 570100;海南医学院国家卫生健康委员会热带病防治重点实验室,海南 海口 571199
- 折叠
摘要
慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是目前世界上常见和导致老年患者死亡的重要疾病之一,以持续气流受限、不可逆性慢性气道阻塞为特征,易导致多种并发症及伴随症状,极大地影响了个人生活质量,加重家庭及社会的经济负担.肺栓塞为COPD合并症之一,可导致肺血液循环及呼吸衰竭,有极高的死亡风险.但因其临床症状与COPD急性加重期症状重叠,缺乏特异的临床表现及实验室检查,易被误诊和忽略,从而延误患者治疗,影响预后.本文将从COPD合并肺栓塞的临床诊疗方面进行阐述,为早期识别COPD合并肺栓塞患者及病情严重程度提供一定价值.
Abstract
Chronic obstructive pulmonary disease(COPD)is one of the most common and important diseases leading to the death of elderly patients in the world at present.It is characterized by continuous airflow restriction and irreversible chronic air-way obstruction,which can easily lead to a variety of complications and accompanying symptoms,greatly affecting the quality of life of individuals and increasing the economic burden of families and society.Pulmonary embolism is one of the complications of COPD,which can lead to pulmonary blood circulation and respiratory failure,with a high risk of death.However,because its clini-cal symptoms overlap with the symptoms of acute exacerbation of COPD and lack of specific clinical manifestations and laboratory tests,it is easy to be misdiagnosed and ignored,thus delaying the treatment of patients and affecting the prognosis.This article will elaborate on the clinical diagnosis and treatment of COPD combined with pulmonary embolism,providing certain value for ear-ly identification of COPD patients combined with pulmonary embolism and the severity of the condition.
关键词
慢性阻塞性肺疾病/肺栓塞/诊断/风险评估Key words
COPD/Pulmonary embolism/Diagnosis/Risk assessment引用本文复制引用
基金项目
国家重点研发计划(2022YFC2305004)
海南省重点研发计划(ZDYF2020223)
海南省科技计划重大项目(ZDKJ2021036)
海南省重点研发计划国际科技合作项目(GHYF2022011)
国家自然科学基金(82260001)
国家自然科学基金(82160012)
出版年
2024
国家科技期刊平台
NSTL
维普
万方数据